Pm Bronchial Asthma
-
Upload
sariidamiharti -
Category
Documents
-
view
256 -
download
0
Transcript of Pm Bronchial Asthma
-
8/3/2019 Pm Bronchial Asthma
1/32
PRESENTED BYDr.ASHA V SASI2ND MD CR DEPT
www.similima.com 1
-
8/3/2019 Pm Bronchial Asthma
2/32
Asthma is characterised by chronic airwayinflammation and increased airway hyper-
responsiveness leading to symptoms of wheeze,cough, chest tightness and dyspnoea.
It is characterised functionally by the presenceof airflow obstruction which is variable over
short periods of time, or is reversible withtreatment.
www.similima.com 2
-
8/3/2019 Pm Bronchial Asthma
3/32
The prevalence of asthma increased steadily over the
latter part of the last century in countries with aWestern lifestyle and is also increasing in developingcountries.
Current estimates suggest that 300 million people
world-wide suffer from asthma and an additional 100million may be diagnosed with asthma by 2025.
In childhood, asthma is more common in boys, butfollowing puberty females are more frequently
affected. The socio-economic impact of asthma is enormous,
particularly when poor control leads to days lost fromschool or work, hospital admissions and, for somepatients, a premature death. www.similima.com 3
-
8/3/2019 Pm Bronchial Asthma
4/32
Dietary intake may be important. Milk fat andantioxidants such as vitamin E and selenium may
protect against the development of asthma inchildren; however, in other studies early exposure tocows' milk protein has been linked to the developmentof atopy and asthma.
higher levels of Lactobacillus in the gut may protectagainst the development of atopic disease.
www.similima.com 4
-
8/3/2019 Pm Bronchial Asthma
5/32
The increase in asthma may also be linked to therise of obesity in Western society throughmechanical mechanisms such as gastro-oesophageal reflux.
Shared genetic traits modification of the immune system by diet, or
alteration of airway responsiveness by hormones
are, however, alternative explanations.
www.similima.com 5
-
8/3/2019 Pm Bronchial Asthma
6/32
In some circumstances the appearance of asthmarelates to the use of medications.
Beta-adrenoceptor antagonists (-blockers-even whenadministered topically as eye drops) may inducebronchospasm.
Aspirin and other non-steroidal anti-inflammatory
drugs are associated with asthma in about 10% ofpatients. This is believed to reflect a shift in the metabolism of
arachidonic acid from the cyclo-oxygenase pathwaygenerating prostaglandins, towards the lipo-oxygenasepathway generating cysteinyl leukotrienes.
Aspirin-sensitive asthma is often associated withrhinosinusitis and nasal polyps
www.similima.com 6
-
8/3/2019 Pm Bronchial Asthma
7/32www.similima.com 7
-
8/3/2019 Pm Bronchial Asthma
8/32
extrinsic Intrinsic(cryptogenic)
External factor identifiable No such factor
Serum shows high levels of IgE &IgGNo raised Ab levels but increasedeosinophils present ,aspirinsensitivity, & presence of nasal
polypAtopic manifestations may bepresent
No atopy
Dermatological and respiratory s/sshow a see-saw relationship
Not associated with skin s/s
Positive family history present
Affects persons of 10-15 yrs Affects persons over 40 yrs
www.similima.com 8
-
8/3/2019 Pm Bronchial Asthma
9/32
Causes House dust Pollen Fungi Animal hairs Insect scales Fumes and drugs food Infection with respiratory syncitial virus Exercise induced asthma Exposure to cold
www.similima.com 9
-
8/3/2019 Pm Bronchial Asthma
10/32
Once sensitization occurs these antigens releasechemical mediators from the mast cells byinteracting with the IgE molecules on theirsurface- Type 1 hypersensitivity reaction-immediate asthmatic paroxysm
Some times type 3 hypersensitivity reaction alsooccurs and it is mediated by IgG delayed
paroxysm
www.similima.com 10
-
8/3/2019 Pm Bronchial Asthma
11/32
The inhalation of an allergen in a sensitised atopicasthmatic patient results in a two-phase
bronchoconstrictor response . The inhaled allergen rapidly interacts with mucosal
mast cells via an IgE-dependent mechanism,resulting in the release of mediators such as
histamine and the cysteinyl leukotrienes withresulting bronchoconstriction. In persistent asthma a chronic and complex
inflammatory response ensues, which ischaracterised by an influx of numerous inflammatory
cells, the transformation and participation of airwaystructural cells, and the secretion of an array ofcytokines, chemokines and growth factors
www.similima.com 11
-
8/3/2019 Pm Bronchial Asthma
12/32
Airflow limitation Usually reversesspontaneously or with treatment
Airway hyper-reactivity Exaggerated
bronchoconstriction to a wide range of non-specific stimuli, e.g. exercise, cold air Airway inflammation :Eosinophils, lymphocytes,
mast cells, neutrophils; associated oedema,
smooth muscle hypertrophy and hyperplasia,thickening of basement membrane, mucousplugging and epithelial damage
www.similima.com 12
-
8/3/2019 Pm Bronchial Asthma
13/32
With increasing severity and chronicity of thedisease, remodelling of the airway occurs,leading to fibrosis of the airway wall, fixednarrowing of the airway and a reduced responseto bronchodilator medication
www.similima.com 13
-
8/3/2019 Pm Bronchial Asthma
14/32
Typical symptoms include recurrent episodes of breathlessness wheezing,
cough. chest tightness
Common precipitants include
exercise, particularly in cold weather,
exposure to airborne allergens pollutants
viral upper respiratory tract infections (beware the coldthat 'goes to the chest' or takes more than 10 days toclear).
www.similima.com 14
-
8/3/2019 Pm Bronchial Asthma
15/32
Moderately severe cases the patient isorthopneic,cyanosed, and accessory musclesof respiration are active
Ineffective cough with tenacious mucoidexpectoration
Pulse rapid BP normal or elevated
Pulsus paradoxus in severe cases
www.similima.com 15
-
8/3/2019 Pm Bronchial Asthma
16/32
Chest expansion diminished ie,less than 2cmduring attack.
Expiratory wheeze heard all over the chest. Patients with mild intermittent asthma are
usually asymptomatic betweenexacerbations which occur during viralrespiratory tract infections or after exposureto allergens.
In persistent asthma the pattern is one of
chronic wheeze and breathlessness
www.similima.com 16
-
8/3/2019 Pm Bronchial Asthma
17/32
a diurnal pattern, symptoms being worse in theearly morning.
Particularly when asthma is poorly controlled,symptoms such as cough and wheeze disturb
sleep and have led to the use of the term'nocturnal asthma'. Cough may be the dominant symptom in some
patients and the lack of wheeze or
breathlessness may lead to a delay in reachingthe diagnosis of so-called 'cough-variantasthma'.
www.similima.com 17
-
8/3/2019 Pm Bronchial Asthma
18/32
www.similima.com 18
-
8/3/2019 Pm Bronchial Asthma
19/32
www.similima.com 19
-
8/3/2019 Pm Bronchial Asthma
20/32
Occupational asthma is now the mostcommon form of occupational respiratorydisorder and accounts for around 5% of alladult-onset asthma.
This should be considered in all adultasthmatics of working age, particularly ifsymptoms improve during time away from
work, e.g. weekends or holidays. Atopic individuals and smokers appear to be
at increased risk.
www.similima.com 20
-
8/3/2019 Pm Bronchial Asthma
21/32
Early diagnosis and removal from exposureleads to a significantly improved prognosisand may result in cure.
The recognition of occupational asthma hasimportant medico-legal implications andshould prompt screening of the workplaceand other employees .
www.similima.com 21
-
8/3/2019 Pm Bronchial Asthma
22/32
The diagnosis of asthma is made on the basis of a
compatible clinical history combined with thedemonstration of variable airflow obstruction
Eosinophilia Sputum reveals eosinophils. Sputum shows eosinophils, mucus plugs and
curschmanns spirals. Purulent sputum indicative of respiratory infection. Culture reveals the infecting organisms Pulmonary function tests
Compatible clinical historyplus either/or: FEV1 15% (and 200 ml) increase following
administration of a bronchodilator/trial of corticosteroids > 20% diurnal variation on 3 days in a week FEV
1 15% decrease after 6 mins of exercise
www.similima.com 22
-
8/3/2019 Pm Bronchial Asthma
23/32
Acute asthma is accompanied by hyperinflation, lobar collapse may be seen if mucus has occluded
a large bronchus.
Flitting infiltrates, on occasion accompanied bylobar collapse, suggest asthma complicated byallergic bronchopulmonary aspergillosis (ABPA).
An HRCT scan may be useful to detect
bronchiectasis
www.similima.com 23
-
8/3/2019 Pm Bronchial Asthma
24/32
An elevated sputum or peripheral blood
eosinophil count may be observed.
The serum total IgE is typically elevated inatopic asthma. Skin prick tests are simple and provide a
rapid assessment of atopy.
Measurement of allergen-specific IgE.
www.similima.com 24
-
8/3/2019 Pm Bronchial Asthma
25/32
Induced sputum and exhaled breath allow
the non-invasive assessment of airwayinflammation and may prove useful in thediagnosis of asthma and assist in themonitoring of disease activity.
www.similima.com 25
-
8/3/2019 Pm Bronchial Asthma
26/32
Achieve and maintain control of symptoms Prevent asthma exacerbations Maintain pulmonary function as close to normal
as possible Avoid adverse effects from asthma medications Prevent development of irreversible airflow
limitation Prevent asthma mortality
Patient education Avoidance of aggravating factors
www.similima.com 26
-
8/3/2019 Pm Bronchial Asthma
27/32
PEF 33-50% predicted (< 100 l/min) SpO2 < 92% or PaO2 < 8 kPa (60 mmHg)
(especially if being treated with oxygen) Normal PaCO2 Silent chest Cyanosis Feeble respiratory effort Bradycardia or arrhythmias Hypotension
Exhaustion Confusion Coma
www.similima.com 27
-
8/3/2019 Pm Bronchial Asthma
28/32
PEF 33-50% predicted (< 200 l/min) Respiratory rate 25/min Heart rate 110/min
Inability to complete sentences in 1 breath
www.similima.com 28
-
8/3/2019 Pm Bronchial Asthma
29/32
Bronchitis Bronchiectasis Pulmonary fibrosis
www.similima.com 29
-
8/3/2019 Pm Bronchial Asthma
30/32
www.similima.com 30
-
8/3/2019 Pm Bronchial Asthma
31/32
www.similima.com 31
-
8/3/2019 Pm Bronchial Asthma
32/32
Management Oxygen therapy Iv fluids
HOMOEOPATHIC MANAGEMENT Respiration asthmatic(synthesis) Diseases asthma(Murphy) Respiration asthma(BBCR) Asthma bronchial(Phatak) Respiratory system asthma(Boericke)